---
title: An update on one-dose HPV vaccine studies, immunobridging and humoral immune
  responses - A meeting report
date: '2023-09-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37680853/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230908181252&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'The 12th HPV Prevention and Control meeting was held on June 2-3, 2022,
  in Antwerp, Belgium. This technical meeting focused on several topics. This report
  summarises the discussions and lessons learned on two topics: an update on one-dose
  HPV vaccination studies and humoral immune responses upon HPV vaccination. Long-term
  follow-up studies from Costa Rica (eleven years) and India (ten years) report stable
  levels of antibodies after a single HPV vaccination. High vaccine effectiveness
  ...'
disable_comments: true
---
The 12th HPV Prevention and Control meeting was held on June 2-3, 2022, in Antwerp, Belgium. This technical meeting focused on several topics. This report summarises the discussions and lessons learned on two topics: an update on one-dose HPV vaccination studies and humoral immune responses upon HPV vaccination. Long-term follow-up studies from Costa Rica (eleven years) and India (ten years) report stable levels of antibodies after a single HPV vaccination. High vaccine effectiveness ...